ITI Pharma and Healthcare Fund Regular vs SBI Healthcare Opportunities Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Chart Comparison
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹166 Cr | ₹2760 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 14 Jul 1999 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open-ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 32% |
| Expense Ratio | 2.34 | 2 |
| Manager | Rohan Korde | Pradeep Kesavan |
| ISIN Code | INF00XX01BL5 | INF200K01446 |
| Exits Load | Exit load of 1% if redeemed within 12 months./365 | Exit load of 0.50% if redeemed within 15 days/365 |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 1 Month | -3.03% | -2.14% |
| 6 Month | 21.21% | 18.56% |
| 1 Year | 43.4% | 42.71% |
| 3 Year | 18.22% | 22.9% |
| 5 Year | - | 28.22% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 40.97% | 44.48% |
| 3 Year | - | 35.88% |
| 5 Year | - | 28.53% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 1 Year | 20.74% | 14.51% |
| 3 Year | 19.19% | 17.07% |
| 5 Year | - | 12.42% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Standard Deviation | 14.52% | 14.02% |
| Sharp | - | 0.78% |
| Beta | - | 0.87% |
| Alpha | - | 3.06% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Name | Rohan Korde | Pradeep Kesavan |
| Total AUM | ₹4626 Cr | ₹434274 Cr |
| Fund Manage | 10 | 43 |
| ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Others | 0.48 | 8.5 |
| Mid Cap | 28.05 | 25.23 |
| Small Cap | 32.19 | 36.36 |
| Large Cap | 39.28 | 29.91 |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Others | 0.48 | 8.5 |
| Healthcare | 96.77 | - |
| Chemicals | 2.75 | - |
| Pharmaceuticals & Biotechnology | - | 58.42 |
| Healthcare Services | - | 24.75 |
| Chemicals & Petrochemicals | - | 3.9 |
| Healthcare Equipment & Supplies | - | 4.43 |
Top Comparisons
Nippon India Gold Savings Fund-Growth plan- Growth Option
3Y Returns13.91%
Nippon India Gold Savings Fund-Growth plan- Growth Option
3Y Returns13.91%
Canara Robeco Equity Hybrid Fund - Regular Plan - Growth Option
3Y Returns11.33%
LIC MF Equity Hybrid Fund-Growth
3Y Returns10.12%
ITI Banking and Financial Services Fund Regular - Growth
3Y Returns0%
UTI Banking and Financial Services Fund - Regular Plan - Growth Option
3Y Returns11.56%
LIC MF Bond Fund-Regular Plan-Growth
3Y Returns5.83%
UTI Medium to Long Duration Fund- Regular Plan - Growth
3Y Returns7.91%